Point-of-care COVID-19 testing in the emergency department: current status and future prospects
- 11 November 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Molecular Diagnostics
- Vol. 21 (12), 1333-1340
- https://doi.org/10.1080/14737159.2021.2005582
Abstract
This expert review outlines current and future point of care technologies for the diagnosis of the SARS-CoV 2 virus, which is responsible for causing coronavirus disease COVID-19 in the emergency department. COVID-19 first emerged in late 2019 and is responsible for a range of presentations from minor upper respiratory tract symptoms to severe pneumonia and multisystem organ failure. Among the technologies available include the gold standard of molecular point of care tests as well as antigen detection tests. We discuss point of care molecular tests including multiplex, targeted and single plex panels as well as various antigen testing methodologies in terms of availability and performance characteristics. In addition, we focus on current testing best practices and considerations for point of care testing in the emergency department based on a search of the literature available in PubMed to date and a review of FDA and CDC guidance. While there have been many advances in SARS-coV2 point of care testing, there remain challenges to implementation in the emergency department setting. A paradigm shift is needed to improve diagnosis and clinical outcomes.Keywords
Funding Information
- funding
This publication has 45 references indexed in Scilit:
- Rapid Multiplex Testing for Upper Respiratory Pathogens in the Emergency Department: A Randomized Controlled TrialOpen Forum Infectious Diseases, 2019
- A Multifaceted Intervention Improves Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care SettingsAcademic Emergency Medicine, 2019
- The role of electronic health record and “add-on” clinical decision support systems to enhance antimicrobial stewardship programsInfection Control & Hospital Epidemiology, 2019
- Doctors’ perceptions of the impact of upfront point-of-care testing in the emergency departmentPLOS ONE, 2018
- Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract InfectionThe New England Journal of Medicine, 2018
- Syndromic Panel-Based Testing in Clinical MicrobiologyClinical Microbiology Reviews, 2018
- Multisite Exploration of Clinical Decision Making for Antibiotic Use by Emergency Medicine Providers Using Quantitative and Qualitative MethodsInfection Control & Hospital Epidemiology, 2014
- Diagnostic point-of-care tests in resource-limited settingsThe Lancet Infectious Diseases, 2013
- Combating Antimicrobial Resistance: Policy Recommendations to Save LivesClinical Infectious Diseases, 2011
- PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settingsThe Lancet Infectious Diseases, 2004